136 drugs may disappear from Ukrainian pharmacies

15 November 2012 11:35  7224455 025002
136 drugs may disappear from Ukrainian pharmacies

On January 1, 136 drugs that have no analogues in the Ukrainian market may disappear from Ukrainian pharmacies.

This was stated by the Head of the State Drugs Service Oleksiy Solovyov, writes the "Kommersant-Ukraine".

"The number of drugs that can be replaced with Ukrainian counterparts, is much higher - 1300" - said Solovyov.

According to him, pharmaceutical manufacturers have not applied for confirmation of international certificates of GMP.

"We are talking about companies like Teva (fifth place in sales in Ukraine in 2011), Actavis (15th), STADA (22nd), Bionorica (27th), Orion Pharma and Sopharma", - said Solovyov.


"We have not submitted applications for those plants which are not present in the PIC / S. So next year we will not be able to deliver to Ukraine up to ten drugs" - said the deputy director of STADA CIS Ivan Glushkov.

He explains this by the fact that the volume of products produced by contract factories for the company STADA is relatively small. For example, a factory in Japan produces several hundred million packages per year, about 10 thousand packages are sent to Ukraine.

"The plant will not waste investments to bring its standards up to EU standards for such low amount," - he said.

According to the executive director of the Association of International Pharmaceutical Manufacturers Volodymyr Ignatov, it would take at least six months to certify those enterprises which have not undergone GMP Inspections.

The resolution of the Cabinet, according to which only those drugs may be imported on the territory of Ukraine that have the certificate of GMP, becomes effective on January 1.

Ukrainska pravda

Read also

Post comment

Users posting offensive comments as to other participants of discussion will be banned by moderator without prior warning or explanation. The information related to these users may be provided to law enforcement authorities upon relevant request.Links and advertising messages are prohibited in the comments!

No comments